1. Home
  2. ACIC vs SAGE Comparison

ACIC vs SAGE Comparison

Compare ACIC & SAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACIC
  • SAGE
  • Stock Information
  • Founded
  • ACIC 1999
  • SAGE 2010
  • Country
  • ACIC United States
  • SAGE United States
  • Employees
  • ACIC N/A
  • SAGE N/A
  • Industry
  • ACIC Property-Casualty Insurers
  • SAGE Biotechnology: Pharmaceutical Preparations
  • Sector
  • ACIC Finance
  • SAGE Health Care
  • Exchange
  • ACIC Nasdaq
  • SAGE Nasdaq
  • Market Cap
  • ACIC 556.0M
  • SAGE 571.1M
  • IPO Year
  • ACIC N/A
  • SAGE 2014
  • Fundamental
  • Price
  • ACIC $10.79
  • SAGE $9.12
  • Analyst Decision
  • ACIC Buy
  • SAGE Hold
  • Analyst Count
  • ACIC 1
  • SAGE 18
  • Target Price
  • ACIC $16.00
  • SAGE $9.89
  • AVG Volume (30 Days)
  • ACIC 216.5K
  • SAGE 1.8M
  • Earning Date
  • ACIC 08-06-2025
  • SAGE 07-30-2025
  • Dividend Yield
  • ACIC 4.59%
  • SAGE N/A
  • EPS Growth
  • ACIC 3.21
  • SAGE N/A
  • EPS
  • ACIC 1.49
  • SAGE N/A
  • Revenue
  • ACIC $302,261,000.00
  • SAGE $47,404,000.00
  • Revenue This Year
  • ACIC N/A
  • SAGE $101.71
  • Revenue Next Year
  • ACIC $37.63
  • SAGE $42.30
  • P/E Ratio
  • ACIC $7.41
  • SAGE N/A
  • Revenue Growth
  • ACIC 23.92
  • SAGE N/A
  • 52 Week Low
  • ACIC $8.82
  • SAGE $4.62
  • 52 Week High
  • ACIC $15.08
  • SAGE $13.47
  • Technical
  • Relative Strength Index (RSI)
  • ACIC 52.28
  • SAGE 66.62
  • Support Level
  • ACIC $10.66
  • SAGE $9.10
  • Resistance Level
  • ACIC $10.95
  • SAGE $9.36
  • Average True Range (ATR)
  • ACIC 0.23
  • SAGE 0.10
  • MACD
  • ACIC 0.02
  • SAGE -0.09
  • Stochastic Oscillator
  • ACIC 47.46
  • SAGE 29.69

About ACIC American Coastal Insurance Corporation

American Coastal Insurance Corp is a holding company that underwrites commercial residential property and casualty insurance policies in the United States through its wholly-owned insurance subsidiary.

About SAGE Sage Therapeutics Inc.

Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.

Share on Social Networks: